MedTrace Logo

Evaluation of Cessation Preferences of Menthol Smoker

NCT02020005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-03

No results posted yet for this study

Summary

The primary aim of this study is to determine menthol smokers' perception, product preference, and pattern of use across six products including, mint-flavored nicotine gum; non-flavored nicotine gum; mentholated nicotine inhaler; and non-menthol nicotine inhaler. Participants will undergo an orientation and baseline assessment followed by a 2-week product sampling phase. At the end of the 2 weeks of sampling, subjects will select a product to use during the following 2-week smoking cessation phase. This 2-week abstinence phase is followed by one week of abrupt withdrawal of the product. This study design was successfully used in a study we conducted that examined the smokers' preference for a variety or oral tobacco products.

Conditions

  • Smoking Cessation

Interventions

OTHER

Non-flavored 2mg nicotine gum

OTHER

Non-flavored 4mg nicotine gum

OTHER

Mint-flavored 2mg nicotine gum

OTHER

Mint-flavored 4mg nicotine gum

OTHER

Non-flavored nicotine inhaler

OTHER

Mint-flavored nicotine ihaler

Sponsors & Collaborators

Principal Investigators

  • Kola Okuyemi, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02020005 on ClinicalTrials.gov